KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) EBT Margin (2016 - 2025)

Historic EBT Margin for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to 9.06%.

  • Repligen's EBT Margin rose 98100.0% to 9.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.14%, marking a year-over-year decrease of 141900.0%. This contributed to the annual value of 14.08% for FY2024, which is 269800.0% down from last year.
  • As of Q3 2025, Repligen's EBT Margin stood at 9.06%, which was up 98100.0% from 9.99% recorded in Q2 2025.
  • In the past 5 years, Repligen's EBT Margin registered a high of 28.78% during Q2 2022, and its lowest value of 60.22% during Q4 2024.
  • Its 5-year average for EBT Margin is 11.76%, with a median of 15.65% in 2023.
  • As far as peak fluctuations go, Repligen's EBT Margin tumbled by -762700bps in 2024, and later skyrocketed by 98100bps in 2025.
  • Quarter analysis of 5 years shows Repligen's EBT Margin stood at 18.68% in 2021, then skyrocketed by 52bps to 28.37% in 2022, then crashed by -43bps to 16.06% in 2023, then crashed by -475bps to 60.22% in 2024, then skyrocketed by 115bps to 9.06% in 2025.
  • Its EBT Margin was 9.06% in Q3 2025, compared to 9.99% in Q2 2025 and 4.7% in Q1 2025.